Ambulatory Peritoneal Dialysis

Front Matter....Pages i-xvi
Front Matter....Pages 1-1
The Role of Cholesterol and Lipids in the Atherogenicity of Continuous Ambulatory Peritoneal Dialysis Patients Update 1990....Pages 3-10
Erythropoietin in Continuous Ambulatory Peritoneal Dialysis Patients, 1990 Benefits of the Subcutaneous Route in the First U. S. Experience....Pages 10-14
Solving the Major Problems of Continuous Ambulatory Peritoneal Dialysis....Pages 15-17
Functional and Histological Changes of Peritoneal Membrane in Long-Term Continuous Ambulatory Peritoneal Dialysis....Pages 18-23
Where Are We Going?....Pages 24-27
Front Matter....Pages 29-29
Peritoneal Ultrafiltration Less Efficient with Prolonged Dwell or Excessive Dialysate Dextrose....Pages 31-35
Neostigmine Increases Net Ultrafiltration and Solute Clearances in Peritoneal Dialysis by Reducing Lymphatic Absorption....Pages 36-39
Phosphatidylcholine Increases Ultrafiltration in Continuous Ambulatory Peritoneal Dialysis Patients....Pages 39-41
Effect of Cationic Molecules on the Permeability of the Mesothelium in Vitro....Pages 42-44
Phosphatidylcholine A Physiological Modulator of the Peritoneal Membrane....Pages 44-47
Ultrafiltration Loss in Continuous Ambulatory Peritoneal Dialysis Patients Effects of Intraperitoneal Therapy with Calcium Antagonists....Pages 48-52
A Chemoattractant in Peritoneal Effluent from Continuous Ambulatory Peritoneal Dialysis Patients....Pages 52-56
The Isolation and Culture of Human Mesothelial Cells Characterization of Cyclooxygenase Products....Pages 56-59
Beta-Blockers Induce Functional Changes That Potentially Injure the Peritoneum in Continuous Ambulatory Peritoneal Dialysis Patients....Pages 60-63
Loss of Mesothelial and Microvascular Fixed Anionic Charges during Murine Experimentally Induced Septic Peritonitis....Pages 63-66
Role of Blood Osmolality in the Regulation of Vasopressin Secretion in Continuous Ambulatory Peritoneal Dialysis Patients....Pages 66-71
Lymphatic Absorption in Continuous Ambulatory Peritoneal Dialysis Patients with Normal and High Transperitoneal Glucose Transport....Pages 71-75
The Kinetics of Ultrafiltration during Peritoneal Dialysis in Rats The Role of Lymphatics....Pages 76-78
Dihydroergotamine Lowers Peritoneal Transfer Rates A Hypovolemic Transport Decrease....Pages 79-82
Ultrafiltration Patterns of Dextran and Hydroxyethylstarch during Long-Dwell Peritoneal Dialysis Exchanges in Nonuremic Rats....Pages 83-86
Front Matter....Pages 29-29
Peritoneal Clearances, Ultrafiltration, and Diuresis in Long-Term Continuous Ambulatory Peritoneal Dialysis....Pages 87-90
Effect of Continuous Ambulatory Peritoneal Dialysis and Hemodialysis on the Transport of Inhibitory Factors of Lymphocyte Proliferation Present in Uremic Serum....Pages 91-92
Methotrexate Influences Peritoneal Permeability....Pages 93-97
High Doses of Intraperitoneal Furosemide in Long-Dwell Exchange....Pages 97-100
Calcium Peritoneal Mass Transfer in Continuous Ambulatory Peritoneal Dialysis....Pages 101-103
Structural Changes in Peritoneal Vessels during Continuous Ambulatory Peritoneal Dialysis A Model for the Study of Diabetic Microangiopathy....Pages 103-109
Mesothelial Hyperplasia after Chronic Intraperitoneal Fluid Administration A Light Microscopy Study in the Rat....Pages 110-112
Mitogenic Effect of the Peritoneal Effluent on Mice Fibroblast Cultures in Continuous Ambulatory Peritoneal Dialysis Patients....Pages 112-115
Oxygen Metabolism of Peritoneal Phagocytes....Pages 115-118
Front Matter....Pages 119-119
The Nutritional Status of Long-Term CAPD Patients....Pages 121-124
Renal Osteodystrophy Bone Mineral Density Loss and Recovery with Treatment....Pages 124-128
Bone Mineralization Defect in Continuous Ambulatory Peritoneal Dialysis Patients....Pages 129-133
Faster Energy Turnover in Peritoneal Dialysis....Pages 133-136
Front Matter....Pages 137-137
One-Year Experience with Swan-Neck Missouri 2 Catheter....Pages 139-142
Thallium 201 Myocardial Imaging in Continuous Ambulatory Peritoneal Dialysis Patients at High Risk of Coronary Artery Disease....Pages 142-144
Tidal Peritoneal Dialysis....Pages 145-149
Absorption of Inulin and High-Molecular-Weight Gelatin Isocyanate Solutions from Peritoneal Cavity of Rats....Pages 149-152
Technical Developments in Continuous Ambulatory Peritoneal Dialysis Summary of Personal Experiences....Pages 152-154
The Use of Hyposmolar Glucose Polymer Solution in Continuous Ambulatory Peritoneal Dialysis A Seven-Day Study....Pages 155-159
Loss of Ultrafiltration Capacity Role of Plasticizers....Pages 159-166
Front Matter....Pages 137-137
Chronic Peritoneal Dialysis Using Curled Catheters....Pages 166-169
Front Matter....Pages 171-171
Immune Defense and Peritonitis in Continuous Ambulatory Peritoneal Dialysis....Pages 173-175
Peritoneal Macrophages of Patients on Continuous Ambulatory Peritoneal Dialysis Show Alterations in Sensitivity and Secretion of Prostaglandins during Peritonitis....Pages 175-181
Interferon Abnormalities and Peritonitis in Continuous Ambulatory Peritoneal Dialysis....Pages 181-186
Association of Staphylococcus aureus Nasal Carriage with Staphylococcus aureus Catheter Exit-Site Infections....Pages 186-188
Survival and Growth of Staphylococcus epidermidis within Phagocytes in Relation to Recurrent Peritonitis in Continuous Ambulatory Peritoneal Dialysis Patients....Pages 189-193
Does Viral Infection Predispose to Peritonitis in Continuous Ambulatory Peritoneal Dialysis?....Pages 193-195
Peritonitis: The Most Serious Complication of Continuous Ambulatory Peritoneal Dialysis Results of a Multi-Center Study....Pages 196-198
Generation and Release of Eicosanoids and Proteolytic Enzymes by Human Peritoneal Macrophages in Response to Staphylococcus epidermidis and the Calcium Ionophore A23187....Pages 199-203
Humoral and Cellular Host-Defense Factors and Peritonitis in Continuous Ambulatory Peritoneal Dialysis Patients....Pages 204-208
Continuous Ambulatory Peritoneal Dialysis Host Defenses and Staphyloccus aureus Role of Opsonins, Fibronectin, Fibrinogen, and Fibrin....Pages 209-213
Long-Term Experience with the Y-Connector in Peritonitis Prevention in Continuous Ambulatory Peritoneal Dialysis Patients....Pages 213-216
Inhibition of Binding of Escherichia coli to Human Peritoneal Macrophages by Peritoneal Effluent from Patients on Peritoneal Dialysis....Pages 217-220
Use of Exudate Smears for Diagnosis of Peritoneal Catheter Exit-Site Infection....Pages 220-222
Early Bacteriological Diagnosis of Continuous Ambulatory Peritoneal Dialysis Peritonitis with the Use of a Cytocentrifuge....Pages 223-226
Front Matter....Pages 227-227
USA CAPD Registry 1987 Report Highlights....Pages 229-231
Multi-Center Study of Outcome of Continuous Ambulatory Peritoneal Dialysis and Hemodialysis Patients A 4-Year Analysis....Pages 232-234
Peritoneal Membrane Function in Myeloma....Pages 235-238
Risk Factors and Outcome of Diabetics on Continuous Ambulatory Peritoneal Dialysis....Pages 238-240
Survival of the “Ideal” Continuous Ambulatory Peritoneal Dialysis Patient....Pages 241-244
Front Matter....Pages 227-227
Efficacy of Hepatitis B Vaccine in Continuous Ambulatory Peritoneal Dialysis Patients Is Influenced by Blood Transfusion....Pages 245-248
Stable Continuous Ambulatory Peritoneal Dialysis Patients Assess the Suitability of New Candidates....Pages 248-250
Individualization of Exchange Volume to Optimize Continuous Ambulatory Peritoneal Dialysis....Pages 251-253
Postural Hypotension with Glucose Ingestion in Patients on Continuous Ambulatory Peritoneal Dialysis....Pages 254-256
Impact of Increasing Intraperitoneal Volume on Left Ventricular Function in Continuous Ambulatory Peritoneal Dialysis Patients....Pages 256-259
Continuous Cycling Peritoneal Dialysis Wet Is Better Than Dry....Pages 259-263
Comparative Evaluation of Hemodialysis and Continuous Ambulatory Peritoneal Dialysis A Multi-Center Study....Pages 264-266
Continuous Ambulatory Peritoneal Dialysis for the AIDS Patient....Pages 266-269
Comparative Study of Muzolimine and Furosemide in Continuous Ambulatory Peritoneal Dialysis Patients....Pages 269-272
Successful Joint Care of Continuous Ambulatory Peritoneal Dialysis Patients with Two District General Hospitals....Pages 272-273
The Benefits of Long-Life Tubing in Continuous Ambulatory Peritoneal Dialysis....Pages 274-276
Effect of Protein or Amino Acid Supplementation on the Nutritional Status of Patients on Continuous Ambulatory Peritoneal Dialysis....Pages 276-280
New Strategy following Peritoneal Catheter Implantation in Continuous Ambulatory Peritoneal Dialysis....Pages 280-282
Treatment of Refractory Congestive Heart Failure by Continuous Ambulatory Peritoneal Dialysis....Pages 283-286
Vitamin Deficiencies in Continuous Ambulatory Peritoneal Dialysis Patients Effects of Supplementation....Pages 287-293
Leakage of Dialysate across the Diaphragm....Pages 294-297
Continuous Ambulatory Peritoneal Dialysis — An Adequate Therapy in Developing Countries....Pages 298-301
Front Matter....Pages 303-303
Acute Peritoneal Dialysis in Premature and Newborn Infants....Pages 305-308
Peritoneal Dialysis in Acute Renal Failure in the Neonate Limits and Complications....Pages 309-311
The Optimal Dialysis Regimen for Children Undergoing Different Continuous Cycling Peritoneal Dialysis Protocols....Pages 311-315
Front Matter....Pages 303-303
Intracellular Amino Acids in Children on Continuous Ambulatory Peritoneal Dialysis....Pages 315-317
Efficiency of High-Volume Continuous Ambulatory Peritoneal Dialysis in Children....Pages 318-320
Outpatient Cycler Peritoneal Dialysis for Home Failure, Hemodialysis Failure, AV Access Failure, and Cardiovascular Instability....Pages 321-323
Back Matter....Pages 325-340